Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats (Q46118947)

19 December 2017

title

Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats (English)

1 reference

19 December 2017

0 references

1 reference

M Berthiaume

1

1 reference

19 December 2017

M Laplante

2

1 reference

19 December 2017

W T Festuccia

3

1 reference

19 December 2017

J P Berger

4

1 reference

19 December 2017

R Thieringer

5

1 reference

19 December 2017

Y Deshaies

6

1 reference

19 December 2017

language of work or name

English

0 references

publication date

17 February 2009

1 reference

19 December 2017

International Journal of Obesity

published in

1 reference

19 December 2017

volume

33

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

601-604

1 reference

19 December 2017

Abdominal obesity and metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

11beta-hydroxysteroid dehydrogenase type 1 and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

inferred from DOI database lookup

7 January 2021

based on heuristic

Involvement of adipose tissues in the early hypolipidemic action of PPARgamma agonism in the rat

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2009.33

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/IJO.2009.33

1 reference

19 December 2017

1 reference

19 December 2017